|
1
|
Parkin DM, Bray F, Ferlay J and Pisani P:
Global cancer statistics, 2002. CA Cancer J Clin. 55:74–108. 2005.
View Article : Google Scholar
|
|
2
|
Enzinger PC and Mayer RJ: Esophageal
cancer. N Engl J Med. 349:2241–2252. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Tomasetto C, Moog-Lutz C, Régnier CH,
Schreiber V, Basset P and Rio MC: Lasp-1 (MLN 50) defines a new LIM
protein subfamily characterized by the association of LIM and SH3
domains. FEBS Lett. 373:245–249. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Tomasetto C, Régnier C, Moog-Lutz C,
Mattei MG, Chenard MP and Lidereau R: Identification of four novel
human genes amplified and overexpressed in breast carcinoma and
localised to the q11eq21.3 region of chromosome 17. Genomics.
28:367–376. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Schreiber V, Moog-Lutz C, Régnier CH,
Chenard MP, Boeuf H and Vonesch JL: Lasp-1, a novel type of
actin-binding protein accumulating in cell membrane extensions. Mol
Med. 4:675–687. 1998.PubMed/NCBI
|
|
6
|
Chew CS, Chen X, Parente JA Jr, Tarrer S,
Okamoto C and Qin HY: Lasp-1 binds to non-muscle F-actin in vitro
and is localized within multiple sites of dynamic actin assembly in
vivo. J Cell Sci. 115:4787–4799. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Butt E, Gambaryan S, Göttfert N, Galler A,
Marcus K and Meyer HE: Actin binding of human LIM and SH3 protein
is regulated by cGMP- and cAMP-dependent protein kinase
phosphorylation on serine 146. J Biol Chem. 278:15601–15607. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Keicher C, Gambaryan S, Schulze E, Marcus
K, Meyer HE and Butt E: Phosphorylation of mouse LASP-1 on
threonine 156 by cAMP- and cGMP-dependent protein kinase. Biochem
Biophys Res Commun. 324:308–316. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Nakagawa H, Terasaki AG, Suzuki H, Ohashi
K and Miyamoto S: Short-term retention of actin filament binding
proteins on lamellipodial actin bundles. FEBS Lett. 580:3223–3228.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chew CS, Parente JA Jr, Zhou C, Baranco E
and Chen X: Lasp-1 is a regulated phosphoprotein within the cAMP
signaling pathway in the gastric parietal cell. Am J Physiol.
275:C56–C67. 1998.PubMed/NCBI
|
|
11
|
Chew CS, Parente JA Jr, Chen X, Chaponnier
C and Cameron RS: The LIM and SH3 domain-containing protein,
lasp-1, may link the cAMP signaling pathway with dynamic membrane
restructuring activities in ion transporting epithelia. J Cell Sci.
113:2035–2045. 2000.PubMed/NCBI
|
|
12
|
Lin YH, Park ZY, Lin D, Brahmbhatt AA, Rio
MC and Yates JR III: Regulation of cell migration and survival by
focal adhesion targeting of Lasp-1. J Cell Biol. 165:421–432. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Grunewald TG, Kammerer U, Schulze E,
Schindler D, Honig A and Zimmer M: Silencing of LASP-1 influences
zyxin localization, inhibits proliferation and reduces migration in
breast cancer cells. Exp Cell Res. 312:974–982. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Grunewald TG, Kammerer U, Winkler C,
Schindler D, Sickmann A and Honig A: Overexpression of LASP-1
mediates migration and proliferation of human ovarian cancer cells
and influences zyxin localization. Br J Cancer. 96:296–305. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhao L, Wang H, Liu C, Liu Y, Wang X and
Wang S: Promotion of colorectal cancer growth and metastasis by the
LIM and SH3 domain protein 1. Gut. 59:1226–1235. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chiyomaru T, Enokida H, Kawakami K,
Tatarano S, Uchida Y and Kawahara K: Functional role of LASP1 in
cell viability and its regulation by microRNAs in bladder cancer.
Urol Oncol. 30:434–443. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang B, Feng P, Xiao Z and Ren EC: LIM and
SH3 protein 1 (Lasp1) is a novel p53 transcriptional target
involved in hepatocellular carcinoma. J Hepatol. 50:528–537. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Grunewald TG, Kammerer U, Kapp M, Eck M,
Dietl J and Butt E: Nuclear localization and cytosolic
overexpression of LASP-1 correlates with tumor size and
nodal-positivity of human breast carcinoma. BMC Cancer. 7:198–208.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Cserni G: Evaluation of sentinel lymph
nodes in breast cancer. Histopathology. 46:697–702. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liotta LA and Kohn EC: The
microenvironment of the tumour-host interface. Nature. 411:375–379.
2001. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang W, Goswami S and Sahai E: Tumor cells
caught in the act of invading: their strategy for enhanced cell
motility. Trends Cell Biol. 15:138–145. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ridley AJ, Schwartz MA and Burridge K:
Cell migration: integrating signals from front to back. Science.
302:1704–1709. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Rachlin AS and Otey CA: Identification of
palladin isoforms and characterization of an isoform-specific
interaction between Lasp-1 and palladin. J Cell Sci. 119:995–1004.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li B, Zhuang L and Trueb B: Zyxin
interacts with the SH3 domains of the cytoskeletal proteins
LIM-nebulette and Lasp-1. J Biol Chem. 279:20401–20410. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hammarstrom A, Berndt KD and Sillard R:
Solution structure of a naturally-occurring zinc-peptide complex
demonstrates that the N-terminal zinc-binding module of the Lasp-1
LIM domain is an independent folding unit. Biochemistry.
35:12723–12732. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Beckerle MC: Zyxin: zinc fingers at sites
of cell adhesion. Bioessays. 19:949–957. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kadrmas JL and Beckerle MC: The LIM
domain: from the cytoskeleton to the nucleus. Nat Rev Mol Cell
Biol. 5:920–931. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
28
|
Spence HJ, McGarry L and Chew CS: AP-1
differentially expressed proteins Krp1 and fibronectin
cooperatively enhance RhoROCK-independent mesenchymal invasion by
altering the function, localization, and activity of
nondifferentially expressed proteins. Mol Cell Biol. 26:1480–1495.
2006. View Article : Google Scholar
|
|
29
|
Viney RL, Morrison AA and van den Heuvel
LP: A proteomic investigation of glomerular podocytes from a
Denys-Drash syndrome patient with a mutation in the Wilms tumour
suppressor gene WT1. Proteomics. 7:804–815. 2007. View Article : Google Scholar : PubMed/NCBI
|
